Company / Profit Margin
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Profit Margin History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-130.4%
FY2018
5-year range
-
FY2016-FY2018
Trend
-32.3%
vs FY2017
Sector context
#152 of 156
Health Care
What the data says
Among 156 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 3% for profit margin. Declined from -82.0% to -130.4% over the past 2 years.
Based on SEC 10-K filings.
-130.4% in FY2018.
Declined from -82.0% to -130.4% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 156This company -130.4% Sector average -252.5%
▼
+48.3% above sector average
Key checks
Key Insights
- In FY2018, profit margin decreased 32.3% year-over-year.
- Currently 122.1pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | -130.4% | -32.3% |
| FY2017 | -98.6% | -20.3% |
| FY2016 | -82.0% | +70.9% |
As of FY2018 · SEC 10-K · Updated Jun 30, 2026